BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
7,444,457
Share change
-382,587
Total reported value
$2,252,000
Price per share
$0.24
Number of holders
48
Value change
-$619,003
Number of buys
13
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q1 2022

As of 31 Mar 2022, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,444,457 shares. The largest 10 holders included HGC Investment Management Inc., ARISTEIA CAPITAL LLC, CITADEL ADVISORS LLC, Corbin Capital Partners, L.P., KINGSTOWN CAPITAL MANAGEMENT L.P., Q Global Advisors, LLC, Sage Rock Capital Management LP, Atalaya Capital Management LP, Linden Advisors LP, and Magnetar Financial LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.